Citation Impact
Citing Papers
Systemic Diseases Caused by Oral Infection
2000
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2017 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
Infective Endocarditis
2005 Standout
Surface Adhesins of Staphylococcus aureus
2006
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2014 Standout
2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary
2014 Standout
The MyD88-Dependent, but Not the MyD88-Independent, Pathway of TLR4 Signaling Is Important in Clearing Nontypeable Haemophilus influenzae from the Mouse Lung
2005 StandoutNobel
Infective Endocarditis in Adults: Diagnosis, Antimicrobial Therapy, and Management of Complications
2015 Standout
Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments
1998
Extracellular-matrix-binding proteins as targets for the prevention of Staphylococcus aureus infections
1999
The Impact of Penicillinase on Cefamandole Treatment and Prophylaxis of Experimental Endocarditis Due to Methicillin‐ResistantStaphylococcus aureus
1998
Basic aspects of the pathogenesis of staphylococcal polymer-associated infections
1999
Prophylaxis of infective endocarditis: current tendencies, continuing controversies
2008
Iron, Infections, and Anemia of Inflammation
1997
Prosthetic-Joint Infections
2004 Standout
Pathogenesis of streptococcal and staphylococcal endocarditis
2002
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
SdrG, a Fibrinogen-binding Bacterial Adhesin of the Microbial Surface Components Recognizing Adhesive Matrix Molecules Subfamily from Staphylococcus epidermidis, Targets the Thrombin Cleavage Site in the Bβ Chain
2001
β-Neurexin Is a Ligand for the Staphylococcus aureus MSCRAMM SdrC
2010 StandoutNobel
On the Role ofStaphylococcus aureusSortase and Sortase‐Catalyzed Surface Protein Anchoring in Murine Septic Arthritis
2002
Efficacy of levofloxacin in the treatment of experimental endocarditis caused by viridans group streptococci
1999
Transfusion Medicine — Blood Transfusion
1999 Standout
Evidence for autolysin‐mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface
1997
Waves of resistance: Staphylococcus aureus in the antibiotic era
2009 Standout
The presence of both bone sialoprotein-binding protein gene and collagen adhesin gene as a typical virulence trait of the major epidemic cluster in isolates from orthopedic implant infections
2009
Contribution of Coagulases towards Staphylococcus aureus Disease and Protective Immunity
2010
The Cost Effectiveness of Preoperative Autologous Blood Donations
1995 Standout
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Deferoxamine Therapy and Mucormycosis in Dialysis Patients: Report of an International Registry
1991
Antibiotic resistance and its cost: is it possible to reverse resistance?
2010 Standout
Estimated Risk of Endocarditis in Adults with Predisposing Cardiac Conditions Undergoing Dental Procedures With or Without Antibiotic Prophylaxis
2006
Bacterial biofilms: from the Natural environment to infectious diseases
2004 Standout
Platelets and the innate immune system: mechanisms of bacterial‐induced platelet activation
2011
Neutrophil extracellular traps in immunity and disease
2017 Standout
Role of Staphylococcus aureus surface adhesins in orthopaedic device infections: are results model-dependent?
1997
Clumping factor B (ClfB), a new surface‐located fibrinogen‐binding adhesin of Staphylococcus aureus
1998
Physiological heterogeneity in biofilms
2008 Standout
Identification of Residues in the Staphylococcus aureus Fibrinogen-binding MSCRAMM Clumping Factor A (ClfA) That Are Important for Ligand Binding
2001
A review of the biomaterials technologies for infection-resistant surfaces
2013 Standout
Ribosomal crystallography: a flexible nucleotide anchoring tRNA translocation, facilitates peptide‐bond formation, chirality discrimination and antibiotics synergism
2004 StandoutNobel
Loss of Clumping Factor B Fibrinogen Binding Activity byStaphylococcus aureus Involves Cessation of Transcription, Shedding and Cleavage by Metalloprotease
2001
Vancomycin-Resistant Enterococcal Infections
2000 Standout
Implant infections: adhesion, biofilm formation and immune evasion
2018 Standout
Signal Transduction by a Death Signal Peptide
2000 StandoutNobel
In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin
2010
Mucormycosis: association with deferoxamine therapy
1989
Adhesion, invasion and evasion: the many functions of the surface proteins of Staphylococcus aureus
2013
Surface protein adhesins of Staphylococcus aureus
1998
Community-acquired pneumonia
1998
Disorders of Iron Metabolism
1999 Standout
Disseminated Zygomycosis: Report of Four Cases and Review
1989
Leukocyte engagement of fibrin(ogen) via the integrin receptor αMβ2/Mac-1 is critical for host inflammatory response in vivo
2004
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
Methicillin-resistant Staphylococus aureus and vancomycin-resistant enterococci: therapeutic realities and possibilities
1997
Infective endocarditis
2004 Standout
Staphylococcus aureusInfections
1998 Standout
Reports of 355 transfusion‐associated deaths: 1976 through 1985
1990 Standout
Thrombosis as an intravascular effector of innate immunity
2012 Standout
Antifouling Coatings: Recent Developments in the Design of Surfaces That Prevent Fouling by Proteins, Bacteria, and Marine Organisms
2010 Standout
Clumping factor A ofStaphylococcus aureusinhibits phagocytosis by human polymorphonuclear leucocytes
2006
Staphylococcus aureus interactions with the endothelium
2005
Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies
2006 Standout
Regulation of growth inhibition at high temperature, autolysis, transformation and adherence in Streptococcus pneumoniae by ClpC
2000 StandoutNobel
Direct Detection of Bacterial Biofilms on the Middle-Ear Mucosa of Children With Chronic Otitis Media
2006 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Real-Time In Vivo Bioluminescent Imaging for Evaluating the Efficacy of Antibiotics in a Rat Staphylococcus aureus Endocarditis Model
2004
Fluorine in medicinal chemistry
2007 Standout
Systemic Diseases Caused by Oral Infection
2000
Quinupristin-Dalfopristin Combined with β-Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics
2000
Reassessing the Role of Staphylococcus aureus Clumping Factor and Fibronectin-Binding Protein by Expression in Lactococcus lactis
2001
BactericidalActivities of Daptomycin, Quinupristin-Dalfopristin, and Linezolidagainst Vancomycin-ResistantStaphylococcus aureusinan In Vitro Pharmacodynamic Model with SimulatedEndocardialVegetations
2003
Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics
1996
Induction of Experimental Endocarditis by Continuous Low-Grade Bacteremia Mimicking Spontaneous Bacteremia in Humans
2011
A Novel Mechanism of Rapid Nuclear Neutrophil Extracellular Trap Formation in Response to Staphylococcus aureus
2010 Standout
Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children
2011 Standout
Fibrinogen and fibronectin binding cooperate for valve infection and invasion in Staphylococcus aureus experimental endocarditis
2005
Methicillin resistance in staphylococci: molecular and biochemical basis and clinical implications
1997
Indications for Cardiac Catheterization and Intervention in Pediatric Cardiac Disease
2011 Standout
IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin
2004 Standout
Transfusion-related mortality: the ongoing risks of allogeneic blood transfusion and the available strategies for their prevention
2009 Standout
Use of a Human-Like Low-Grade Bacteremia Model of Experimental Endocarditis To Study the Role of Staphylococcus aureus Adhesins and Platelet Aggregation in Early Endocarditis
2012
Hepcidin, a key regulator of iron metabolism and mediator of anemia of inflammation
2003 Standout
BAL9141, a Novel Extended-Spectrum Cephalosporin Active against Methicillin-Resistant Staphylococcus aureus in Treatment of Experimental Endocarditis
2002
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Common themes in microbial pathogenicity
1989
Antibiotic prophylaxis of experimental endocarditis after dental extractions.
1988
Staphylococcus Lugdunensis, An Aggressive Coagulase-Negative Pathogen not to be Underestimated
2012
Nonvalvular Cardiovascular Device–Related Infections
2003
The Fibrinogen- and Fibronectin-Binding Domains of Staphylococcus aureus Fibronectin-Binding Protein A Synergistically Promote Endothelial Invasion and Experimental Endocarditis
2008
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
Staphylococcus aureus induces platelet aggregation via a fibrinogen-dependent mechanism which is independent of principal platelet glycoprotein IIb/IIIa fibrinogen-binding domains
1995
Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis
1997
2017 AHA/ACC Focused Update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease
2017 Standout
Influence of erythromycin resistance, inoculum growth phase, and incubation time on assessment of the bactericidal activity of RP 59500 (quinupristin-dalfopristin) against vancomycin-resistant Enterococcus faecium
1997
Transcription of Clumping Factor A in Attached and Unattached Staphylococcus aureus In Vitro and during Device-Related Infection
2002
2015 ESC Guidelines for the management of infective endocarditis
2015 Standout
The Staphylococcal Biofilm: Adhesins, Regulation, and Host Response
2016
Roles for fibrinogen, immunoglobulin and complement in platelet activation promoted by Staphylococcus aureus clumping factor A
2005
Three new members of the serine-aspartate repeat protein multigene family of Staphylococcus aureus
1998
2008 Focused Update Incorporated Into the ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2008 Standout
Functions of Cell Surface Heparan Sulfate Proteoglycans
1999 Standout
Protective efficacy of antibodies to the Staphylococcus aureus type 5 capsular polysaccharide in a modified model of endocarditis in rats
1997
Development of the quinolones
2003
Inflammatory Exposure and Historical Changes in Human Life-Spans
2004 StandoutScience
Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations
1998
The platelet interactivity phenotype of Streptococcus sanguis influences the course of experimental endocarditis
1992
Works of P. Moreillon being referenced
Importance of Genotypic and Phenotypic Tolerance in the Treatment of Experimental Endocarditis Due to Streptococcus gordonii
1997
Antibiotic Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus epidermidis
1994
The Role of Iron Overload in Yersinia enterocolitica and Yersinia pseudotuberculosis Bacteremia in Hemodialysis Patients
1987
Contribution of Clumping Factor B to Pathogenesis of Experimental Endocarditis due to Staphylococcus aureus
2000
Study of Staphylococcus aureus Pathogenic Genes by Transfer and Expression in the Less Virulent Organism Streptococcus gordonii
2001
Endocarditis prophylaxis revisited: experimental evidence of efficacy and new Swiss recommendations. Swiss Working Group for Endocarditis Prophylaxis.
2000
Efficacies of Moxifloxacin, Ciprofloxacin, and Vancomycin against Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus Expressing Various Degrees of Ciprofloxacin Resistance
2001
[Antibiotic resistance in pneumococci].
1996
RP 59500 prophylaxis of experimental endocarditis due to erythromycin-susceptible and -resistant isogenic pairs of viridans group streptococci
1995
Experimental Bacterial Endocarditis After Dental Extractions in Rats with Periodontitis
1987
Role of Staphylococcus aureus coagulase and clumping factor in pathogenesis of experimental endocarditis
1995
Treatment of experimental endocarditis due to erythromycin-susceptible or -resistant methicillin-resistant Staphylococcus aureus with RP 59500
1995